TechNavio's analysts forecast the Global Molecular Diagnostics market to grow
at a CAGR of 11.42 percent over the period 2012-2016. One of the key factors
contributing to this market growth is the increasing investments in genomics and
proteomics research. The Global Molecular Diagnostics market has also been
witnessing a growth in the diagnostics segment. However, the compliance with
regulatory requirements could pose a challenge to the growth of this market.
The Global Molecular Diagnostics Market 2012-2016, has been prepared based on an
in-depth market analysis with inputs from industry experts. The report covers
the Americas, EMEA, and APAC regions; it also covers the market segmentation
based on product types, based on application, and based on technology and its
growth prospects in the coming years. The report also includes a discussion of
the key vendors operating in this market.
Key vendors dominating this space include Abbott Laboratories, Becton, Dickinson
and Co., QIAGEN N.V., and Roche Holding Ltd.
Other vendors mentioned in the report are Affymetrix Inc., Agilent Technologies
Inc., Alere Inc., AmniSure International LLC, Anadys Pharmaceuticals Inc., Bayer
HealthCare AG, Biocartis SA, bioMerieux SA, Bio-Rad Laboratories Inc., Biotest
AG, Carmel Pharma AB, Celera Diagnostics LLC, Cellestis Ltd., Cepheid Inc.,
Cytometers Inc., Danaher Corp., Diagenode SA, Eli Lilly and Co., Eurogentec S.A.,
Evotec AG, GE Healthcare Ltd., Genomic Health Inc., Gen-Probe Inc., Illumina
Inc., Instrumentation Laboratory Co., IRIS International Inc., Janssen Biotech
Inc., KIESTRA Lab Automation BV, Life Technologies Corp., Luminex Corp., Merck
and Co. Inc., mtm laboratories AG, Nanosphere Inc., Novartis AG, PerkinElmer
Inc., Pharmacyclics Inc., PVT Probenverteiltechnik GmbH, Quest Diagnostics Inc.,
Quidel Corp., Safety Syringes Inc., SANYO North America Corp., Siemens
Healthcare, Sirigen Group Limited, St. Jude Medical Inc., Sysmex Corp., and
Thermo Fisher Scientific Inc.
Key questions answered in this report:
What will the market size be in 2015 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
1. Executive Summary
2. List of Abbreviations
4. Market Research Methodology
4.1.1. Market Research Process
4.1.2. Research Design
4.1.3. Research Methodology
5. Scope of the Report
6. Market Landscape
6.1. Market Size and Forecast
6.2. Market Segmentation Based on Product Type
6.3. Market Segmentation Based on Application
6.4. Market Segmentation Based on Technology
6.5. Five Force Analysis
7. Geographical Segmentation
8. Vendor Landscape
9. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Key Information
15.1.3. SWOT Analysis
15.2. Becton, Dickinson and Co.
15.2.1. Business Overview
15.2.2. Key Information
15.2.3. SWOT Analysis
15.3. QIAGEN N.V.
15.3.1. Business Overview
15.3.2. Key Information
15.3.3. SWOT Analysis
15.4. Roche Holding Ltd.
15.4.1. Business Overview
15.4.2. Key Information
15.4.3. SWOT Analysis
16. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Molecular Diagnostics Market 2012-2016 (US$ billion)
Exhibit 3: Global Molecular Diagnostics Market Segmentation
Exhibit 4: Global Molecular Diagnostics Market Segmentation Based on Application
Exhibit 5: Global Molecular Diagnostics Market Segmentation Based on Application
Exhibit 6: Global Molecular Diagnostics Market Segmentation Based on Technology
Exhibit 7: Global Molecular Diagnostics Market Segmentation Based on Technology
Exhibit 8: Global Molecular Diagnostics Market by Geographical Segmentation 2012
Exhibit 9: Global Molecular Diagnostics Market by Vendor Segmentation 2012
Exhibit 10: Key Mergers and Acquisitions in the Global Molecular Diagnostics
Exhibit 11: Business Segmentation of Abbott Laboratories
Exhibit 12: Business Segmentation of Becton, Dickinson and Co.
Exhibit 13: Business Segmentation of QIAGEN N.V.
Exhibit 14: Business Segmentation of Roche Holding Ltd.